Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CCAP vs GCMG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GCMG Captures Overall Composite Edge (49.4 HOLD vs 19.6 STRONG SELL), While CCAP Leads 3–2 on Growth & Valuation Pillars

GCMG Overall Winner 6-Pillar Tally: CCAP 3 – 2 GCMG (1 Tie) Matrix Metrics: CCAP 3 – 7 GCMG

As of Nov 16, 2026, GCM Grosvenor Inc. (GCMG) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (49.4/100 HOLD vs. 19.6/100 STRONG SELL) after splitting the core matrix 7–3 (led by Growth & Scale, Balance Sheet & Cash Flow), while CCAP wins 3–2 across the 6-pillar growth and valuation breakdown. CCAP trades at $10.08 (7.0x Forward P/E, 78.4% operating margin) versus GCMG at $13.21 (12.4x Forward P/E, 27.2% operating margin).

  • Growth vs. Quality Trade-Off: GCMG earns the overall head-to-head edge with a stronger Unified Composite Score (49.4/100 HOLD vs. CCAP 19.6/100 STRONG SELL) and 1.18β · 41% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CCAP vs GCMG
CCAP NASDAQ
Crescent Capital BDC, Inc. Common stock
Institutional Equity
$10.08
-0.49% 1D
Market Cap $372.1M
TTM Revenue $156M
Forward P/E 7.0x
Beta / 30D Vol 0.44β · 50% Vol
Unified Composite Score
19.6 / 100 STRONG SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 61
RSI-14: 61.3 · SMA20: $9.36 · SMA50: $9.42
GCMG NASDAQ Head-to-Head Winner
GCM Grosvenor Inc. Class A Common Stock
Investment Advice
$13.21
-2.15% 1D
Market Cap $828.8M
TTM Revenue $406M
Forward P/E 12.4x
Beta / 30D Vol 1.18β · 41% Vol
Unified Composite Score
49.4 / 100 HOLD
Tech 46.0 Fund 46.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.0 · SMA20: $12.88 · SMA50: $12.90

6-Pillar Scorecard Institutional Category Breakdown (CCAP 3 – 2 GCMG)

Columns: Metric · CCAP · GCMG
1. Valuation Multiples CCAP
Forward P/E 7.0x 12.4x
Trailing P/E 7.4x 25.5x
PEG Ratio 0.89x N/M
EV / Revenue 2.4x 2.0x
2. Growth & Scale GCMG
Revenue Growth (YoY) -15.5% +9.0%
Earnings Growth (YoY) -14.9% +4.1%
TTM Revenue (USD) $156M $406M
Market Cap $372.1M $828.8M
3. Profitability & Quality CCAP
Gross Margin 100.0% 45.7%
Operating Margin 78.4% 27.2%
Net Profit Margin -2.0% 8.0%
Return on Equity (ROE) -0.5% 195.7%
4. Balance Sheet & Cash Flow GCMG
Cash Generation (TTM) N/A $114M EBITDA
Cash Flow Margin N/A 27.9% EBITDA Mgn
Net Cash / Leverage $19.10 Book/Sh · -0.5% ROE $0.54 Book/Sh · 195.7% ROE
Dividend Yield None (0.00%) 3.38%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 25.3% (50th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CCAP
OpEx & R&D Intensity 21.6% of Rev ($34M) 18.5% of Rev ($75M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Asset Management Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CCAP (3) vs GCMG (7)
Institutional Metric CCAP GCMG Criterion Row Edge
Market Capitalization
Scale
$372.1M $828.8M Larger Scale GCMG
Trailing P/E Ratio
Valuation
7.4x 25.5x Lower Multiple CCAP
Forward P/E Ratio
Valuation
7.0x 12.4x Lower Multiple CCAP
Revenue Growth (YoY)
Growth
-15.5% +9.0% Higher Growth GCMG
Operating Margin (TTM)
Profitability
78.4% 27.2% Higher Margin CCAP
Net Profit Margin
Profitability
-2.0% 8.0% Higher Margin GCMG
Return on Equity (ROE)
Capital Efficiency
-0.5% 195.7% Higher ROE GCMG
52-Week Range Position
Momentum
25% ($8–$15) 70% ($9–$15) Stronger Trend GCMG
Beta / 30D Volatility
Risk Regime
0.44β · 50% Vol 1.18β · 41% Vol Lower Realized Risk GCMG
Unified Institutional Score
Composite Signal
19.6 / 100 (STRONG SELL) 49.4 / 100 (HOLD) Higher Composite GCMG
Trailing 12M Revenue (USD)
Operating Scale
$156M $406M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 45.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.89x PEG · 2.4x EV/Rev N/M PEG · 2.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($19.10 Book/Sh · -0.5% ROE) $114M EBITDA ($0.54 Book/Sh · 195.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CCAP +8.08 pp
CCAP: +13.26% · GCMG: +5.18%
3M Horizon GCMG +3.55 pp
CCAP: -6.84% · GCMG: -3.29%
6M Horizon GCMG +31.69 pp
CCAP: -9.03% · GCMG: +22.66%
1Y Horizon GCMG +40.7 pp
CCAP: -25.83% · GCMG: +14.87%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCAP vs GCMG. Trailing 12-month operating profitability (CCAP 78.4% vs GCMG 27.2%) and valuation multiples (CCAP 7.0x vs GCMG 12.4x Forward P/E) are benchmarked directly in Pillar 4 below.

CCAP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$156M
Gross Margin100.0%
Op. Margin78.4%
ROE / Fwd P/E-0.5% · 7.0x
GCMG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$406M
Gross Margin45.7%
Op. Margin27.2%
ROE / Fwd P/E195.7% · 12.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CCAP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CCAP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GCMG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 25.3%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GCMG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CCAP Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $372.1M market capitalization and 78.4% operating margin.
OpEx & R&D Reinvestment 21.6% of Rev ($34M)
90D Engineering Disclosures 0 Published
GCMG Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $828.8M market capitalization and 27.2% operating margin.
OpEx & R&D Reinvestment 18.5% of Rev ($75M)
90D Engineering Disclosures 0 Published

Investor FAQ CCAP vs GCMG Key Questions & Quantitative Answers

As of Nov 16, 2026, GCM Grosvenor Inc. (GCMG) captures the overall head-to-head institutional edge over Crescent Capital BDC, Inc. (CCAP) on higher Unified Composite conviction (49.4/100 HOLD vs. 19.6/100 STRONG SELL) after splitting the core matrix 7–3 (led by Growth & Scale, Balance Sheet & Cash Flow), while CCAP wins 3–2 across the 6-pillar growth and valuation breakdown. CCAP trades at $10.08 (7.0x Forward P/E, 78.4% operating margin) versus GCMG at $13.21 (12.4x Forward P/E, 27.2% operating margin). Growth vs. Quality Trade-Off: GCMG earns the overall head-to-head edge with a stronger Unified Composite Score (49.4/100 HOLD vs. CCAP 19.6/100 STRONG SELL) and 1.18β · 41% Vol risk profile, whereas CCAP leads top-line expansion (-15.5% YoY revenue growth, 0.89x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

GCMG leads the Growth & Scale pillar: CCAP posts -15.5% YoY revenue growth and -14.9% YoY earnings growth on $156M TTM revenue (100.0% gross margin, 78.4% operating margin), compared with GCMG at +9.0% YoY revenue growth and +4.1% YoY earnings growth on $406M TTM revenue (45.7% gross margin, 27.2% operating margin). On trailing 12-month operating scale, CCAP generates $156M in USD-normalized revenue versus $406M for GCMG. In operating R&D and SG&A reinvestment, CCAP deploys 21.6% of Rev ($34M) (0 90-day corporate R&D disclosures) versus 18.5% of Rev ($75M) (0 disclosures) for GCMG.

CCAP screens cheaper on headline valuation multiples. CCAP trades at 7.0x Forward P/E, 7.4x Trailing P/E, 0.89x PEG, and 2.4x EV/Revenue (unreported cash flow margin), whereas GCMG trades at 12.4x Forward P/E, 25.5x Trailing P/E, N/M PEG, and 2.0x EV/Revenue (27.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCAP (-0.5% ROE) versus GCMG (195.7% ROE) capital efficiency.

In options market volatility and institutional positioning, CCAP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 50% Vol realized risk). By comparison, GCMG carries 25.3% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.18β · 41% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.